Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to determine the one-year neurological outcome of patients admitted to an intensive care unit (ICU) for a primary and spontaneous supratentorial intracerebral hemorrhages (ICH).


Clinical Trial Description

ICH represent a diagnostic and therapeutic emergency. ICH account for 20% of strokes with a one-year mortality of more than 45% and an uncertain neurological outcome.

For ICH patients, the main initial challenge is to determine the long term neurological outcomes and adapt the therapeutic strategy.

The majority of primary and spontaneous ICH studies involve patients in stroke units.

The study is an observational type 3 research with all the patients admitted in all the University Hospital of Grenoble Alpes ICUs between July 2012 and July 2017 for a primary and spontaneous supratentorial ICH ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03995940
Study type Observational
Source University Hospital, Grenoble
Contact Catherine Portal
Phone +33.4.76.76.67.29
Email bportal@chu-grenoble.fr
Status Recruiting
Phase
Start date April 30, 2019
Completion date January 2020

See also
  Status Clinical Trial Phase
Completed NCT03153150 - Start or STop Anticoagulants Randomised Trial (SoSTART) Phase 3
Not yet recruiting NCT02782897 - Intravenous Immunoglobulin for Acute Intracranial Hemorrhage Phase 2
Not yet recruiting NCT06429657 - Ketamine for Sedation in Severe Traumatic Brain Injury Phase 4
Completed NCT02811614 - Minimally-invasive Surgery Versus Craniotomy in Patients With Supratentorial Hypertensive Intracerebral Hemorrhage N/A
Completed NCT01689402 - MRI for the Early Evaluation of Acute Intracerebral Hemorrhage
Recruiting NCT05778110 - Multiomic Analysis of Traumatic Brain Injury and Hypertension Intracranial Hemorrhage Lesion Tissue